Open AccessA Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
Author(s) -
Samir H. AssaadKhalil,
Nabil Elkafrawy,
Mohsen Khaled,
Omneya Mogeib,
Hytham Badr,
Ahmed Rashwan,
Mahmoud Youssef,
K. Eltamawy,
Shahnaz Mohamed
Publication year - 2022
Publication title -
evidence-based complementary and alternative medicine
Language(s) - English
Resource type - Journals
eISSN - 1741-4288
pISSN - 1741-427X
DOI - 10.1155/2022/9176026
Subject(s) - type 2 diabetes mellitus , double blind , medicine , capsule , diabetes mellitus , clinical trial , type 2 diabetes , randomized controlled trial , endocrinology , alternative medicine , pathology , biology , botany , placebo
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom